Key takeaway
In an 8-week pilot trial of adults with obesity, 14:10 time restricted eating plus a commercial weight program cut body weight by 8.5% versus 7.1% with 12:12 (difference -1.4%, 95% CI -2.7 to -0.2). Only 60 of 78 participants finished, and the comparator also lost weight, so the added effect is small and uncertain.
Study design
Randomised trial
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
The research question
Time restricted eating, where food is limited to a daily window, is being tested as a weight-loss tool that may extend the metabolic benefits of overnight fasting. The authors tested whether a 14-hour nightly fast, with a low-calorie, high-fat, low-carbohydrate fasting snack at hour 12, improves weight and fasting glucose compared with a 12-hour fast.
Who and how
Pilot randomized controlled trial run remotely from June to October 2020 in men and women with BMI of 30 kg/m2 or higher. Participants were randomized to 14:10 or 12:12 time restricted eating (active comparator) for 8 weeks, with a diet controlled for calories and macronutrients, an exercise program and weekly customized counseling. The primary outcome was change from baseline in body weight in the 14:10 group; fasting blood glucose was also measured.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Of 78 randomized participants, 60 (30 per group) completed 8 weeks.
- 2Least-squares mean weight change was -8.5% (95% CI -9.6 to -7.4; P < 0.001) in the 14:10 group and -7.1% (-8.3 to -5.8; P < 0.001) in the 12:12 group; the between-group difference was -1.4% (-2.7 to -0.2; P < 0.05).
- 3Fasting glucose fell by 7.6 mg/dl in the 14:10 group (95% CI -15.1 to -0.1; P < 0.05) but not significantly in the 12:12 group (-3.1 mg/dl, -10.0 to 3.7).
- 4Both schedules reduced fasting glucose more in people whose baseline level was 100 mg/dl or higher (both P < 0.05).
Limits & uncertainty
- 1This was a pilot trial, and only 60 of 78 randomized participants completed 8 weeks, so dropout could bias results.
- 2Eight weeks is too short to know whether weight loss or glucose changes last.
- 3Both groups also received a commercial weight program with a controlled diet and counseling, so the effect of the fasting window alone cannot be separated; the 12:12 group lost nearly as much.
- 4The 14:10 group's glucose change was barely significant (upper confidence limit -0.1 mg/dl), and the abstract does not report a direct between-group glucose comparison.
What to take from it
Both schedules came with substantial weight loss inside a structured program, and the longer fast added only about 1.4 percentage points. A 12-hour overnight gap may be enough for most people to get started; anyone with diabetes or on glucose-lowering drugs should check with their clinician before changing eating patterns.
Reading your own data
Log the timing of your first and last meals (a food log or app works) alongside morning weight, and compare weekly averages on the same scale rather than single days. If you use a continuous glucose monitor or fingerstick, measure fasting values under the same conditions each time.
How to read this evidence
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Time restricted eating (TRE) is an emerging dietary intervention for weight loss that is hypothesized to reinforce the metabolic benefits of nightly fasting/ketosis. This pilot study investigated the effectiveness of a daily 14-h metabolic fast (14:10 TRE beginning after dinner, a "fasting snack" at hour 12, and ending with breakfast 14 h later) combined with a commercial weight management program on body weight and fasting blood glucose (FBG) in individuals with obesity. We also investigated the effect of the low-calorie, high-fat, low-carbohydrate, and low-protein "fasting snack" on blood glucose.
Methods
This 8-week, randomized, controlled, clinical trial included men and women (BMI ≥ 30 kg/m^(2)) between June and October 2020. Study procedures were conducted remotely. Participants were randomized to 14:10 or 12-h TRE (12:12, active comparator) and prescribed a diet (controlled for calories and macronutrient composition) and exercise program that included weekly customized counseling and support. The primary outcome was change from baseline in body weight in the 14:10 group.
Results
Of the 78 randomized participants, 60 (n = 30/group) completed 8 weeks. The LS mean change from baseline in weight in the 14:10 group was -8.5% (95% CI -9.6 to -7.4; P < 0.001) and -7.1% (-8.3 to -5.8; P < 0.001) in the 12:12 group (between group difference -1.4%; -2.7 to -0.2; P < 0.05). There was a statistically significant LS mean change from baseline to week 8 in FBG in the 14:10 group of -7.6 mg/dl (95% CI -15.1 to -0.1; P < 0.05) but not in the 12:12 group (-3.1 mg/dl, -10.0 to 3.7; P = NS). Both interventions resulted in a larger reduction in FBG in participants with elevated FBG (≥100 mg/dl) at baseline (both P < 0.05).
Conclusions
In participants with obesity who completed 8 weeks of the 14:10 TRE schedule combined with a commercial weight loss program, there was statistically significant and clinically meaningful weight loss and improvements in FBG.
Sources & attribution
Effect of time restricted eating on body weight and fasting glucose in participants with obesity: results of a randomized, controlled, virtual clinical trial.
Peeke PM, Greenway FL, Billes SK, Zhang D, Fujioka K.
Nutrition & diabetes · 2021-01-15
DOI: 10.1038/s41387-021-00149-0 ↗PubMed · 33446635 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

